SALT LAKE CITY, June 24 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) announced it has begun shipping its new V-Force Vibration Therapy units to customers. These new units employ powerful, whole-body vibration technology, which provides neuromuscular training to increase strength, improve balance and enhance flexibility.
Originally developed for the Russian space program to compensate for bone and muscle loss resulting from extended periods in space, whole-body vibration therapy has been the subject of extensive research for many years. Numerous clinical studies indicate effectiveness in the areas of balance/fall prevention, circulation, knee rehabilitation, low back pain, range of motion and a host of other neuromuscular conditions.
"The V-Force technology represents something totally new and unique in our market," stated Larry K. Beardall, executive vice president of sales and marketing. "We've spent the last three months providing demos and training for our distribution channels. They are now ready to launch this new product to the market."
Initial demand for the new V-Force unit has been strong. "We have a sizable waiting list for units and expect it will take several months before production is able to catch up to demand," said Beardall. "In fact, we expect to sell over $500,000 of this product within the first two weeks of its introduction as we attempt to fill the pipeline and satisfy initial demand."
"V-Force is not just an upgrade of existing technology," added Kelvyn H. Cullimore, Jr, Dynatronics' chairman and president. "It represents a new therapeutic modality. The last time we introduced a new modality was light therapy several years ago that resulted in significant improvement in sales."
"Despite challenging general economic conditions," continued Cullimore, "there are many factors pointing to improved performance for Dynatronics including V-force sales, increasing medical supplies business and greater realization of overall cost savings generated over the past few months with the help of Vici Capital. These improvements contribute to very positive momentum for the Company that we believe will accelerate as the general economy begins to improve."
Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.
This press release contains forward-looking statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. Forward-looking statements in this press release include, among others, the statement that the company expects to sell $500,000 of the new product in the first two weeks of its launch and the expectation that the launch of the new product and changes from the company's project with Vici Capital will lead to accelerating positive momentum, based on indications of interest and references to the implementation and expected impact of cost-saving measures in future periods. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, its most recent annual report on Form 10-KSB for the year ended June 30, 2008, and its subsequent quarterly reports on Form 10-Q.
|SOURCE Dynatronics Corporation|
Copyright©2009 PR Newswire.
All rights reserved